Sponsor Pipeline

Devintec Sagl Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
Active Trials by Phase
Not specified
2
Active Trials
NCT IDTitleConditionStatus
Not specified
NCT06681012 Gelsectan® in the Treatment of Patients With Diarrhoea-predominant Irritable Bowel… Irritable Bowel Syndrome (IBS) Recruiting
NCT06984484 Performance and Safety of Afluxin® in Patients With Gastroesophageal Reflux Disease Gastroesophageal Reflux Disease (GERD) Recruiting
Get alerts when Devintec Sagl's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free